Presentation is loading. Please wait.

Presentation is loading. Please wait.

A methacholine challenge dose-response study for development of a pharmacodynamic bioequivalence methodology for albuterol metered-dose inhalers  Peter.

Similar presentations


Presentation on theme: "A methacholine challenge dose-response study for development of a pharmacodynamic bioequivalence methodology for albuterol metered-dose inhalers  Peter."— Presentation transcript:

1 A methacholine challenge dose-response study for development of a pharmacodynamic bioequivalence methodology for albuterol metered-dose inhalers  Peter S. Creticos, MDa, Wallace P. Adams, PhDb, Brent G. Petty, MDc, Lionel D. Lewis, MBBCh, MDc, Gur Jai Pal Singh, PhDd, Arouna P. Khattignavong, MDa, Justina A. Molzon, MS, JDe, Marilyn N. Martinez, PhDd, Paul S. Lietman, MD, PhDc, Roger L. Williams, MDb  Journal of Allergy and Clinical Immunology  Volume 110, Issue 5, Pages (November 2002) DOI: /mai Copyright © 2002 Mosby, Inc. Terms and Conditions

2 Fig. 1 Posterior Bayesian fitting of PD20 as a function of dose for the 15 study subjects. Abscissa scaling is constant for all plots. Ordinate scaling varies with the observed maximal response of individual subjects. The plots reveal dose-response data with low variability (eg, subject 2) and high variability (eg, subject 13). Journal of Allergy and Clinical Immunology  , DOI: ( /mai ) Copyright © 2002 Mosby, Inc. Terms and Conditions


Download ppt "A methacholine challenge dose-response study for development of a pharmacodynamic bioequivalence methodology for albuterol metered-dose inhalers  Peter."

Similar presentations


Ads by Google